Durham, North Carolina 27705

  • Surgical Wound Infection


The primary objective of this pivotal study is to determine if a new antimicrobial dressing, applied to the sternal incisions of cardiac surgical subjects, will demonstrate a decreased cumulative incidence rate(CI) of localized, superficial infections at the sternal incisional site as compared to the control group, regular, non-antimicrobial dressing.


Inclusion Criteria: - Sign an informed consent form that has been approved by the Institutional Review Board. - Adults at least 18 years of age. - Be undergoing cardiopulmonary bypass surgery with a median sternotomy. - Be able to return to the study site, if needed, to have the sternal surgical incision site inspected. Exclusion Criteria: - Be participating concurrently in another clinical trial that involves an investigational drug or device that would interfere with this study. - Be in need of a left ventricular assist device. - Have an active pre-operative infectious process. - Subject is to receive another topical antimicrobial agent (i.e., Dermabond® Topical Skin Adhesive) other than the study dressing (as assigned by the randomization schedule).



Primary Contact:

Study Director
Katie Kavounis, MPH
Tyco Healthcare/Kendall

Backup Contact:


Location Contact:

Durham, North Carolina 27705
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.